Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

AC Immune (ACIU) Income from Continuing Operations (2016 - 2026)

AC Immune has reported Income from Continuing Operations over the past 11 years, most recently at 18900946.3 for Q1 2026.

  • Quarterly Income from Continuing Operations rose 10.7% to 18900946.3 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 82302232.45 through Mar 2026, down 41.87% year-over-year, with the annual reading at 88141158.32 for FY2025, 51.67% down from the prior year.
  • Income from Continuing Operations was 18900946.3 for Q1 2026 at AC Immune, down from 17983063.42 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 6351602.46 in Q3 2024 and troughed at 25593986.06 in Q2 2025.
  • The 5-year median for Income from Continuing Operations is 18927913.25 (2023), against an average of 17360965.7.
  • Year-over-year, Income from Continuing Operations soared 137.06% in 2024 and then crashed 412.11% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 19457720.74 in 2022, then soared by 72.53% to 5345914.91 in 2023, then crashed by 237.25% to 18029196.07 in 2024, then grew by 0.26% to 17983063.42 in 2025, then dropped by 5.1% to 18900946.3 in 2026.
  • Per Business Quant, the three most recent readings for ACIU's Income from Continuing Operations are 18900946.3 (Q1 2026), 17983063.42 (Q4 2025), and 19824236.68 (Q3 2025).